🔍 Breast Tissue in Men — Finding the Cause
♂ Built for men · 8 markers · $208.80
with code CAMERON $232.00
Men with new or growing tissue under one or both nipples, with or without tenderness. On cycle, on TRT, or on nothing at all.
🩸 Order this exact panel — 10% off
All 8 markers load into your cart in one click. No doctor's visit, drawn at any Quest location in the US, results by email in about two weeks. Code CAMERON applies automatically.
Add all 8 markers — $208.80 → Open the full Bloodwork Vault →Why this panel
Breast tissue in a man is driven by the RATIO of estrogen to androgen acting on the breast, not by either hormone alone — which is why it appears at a normal estradiol in a man whose testosterone has fallen, and at a normal testosterone in a man whose estradiol has risen. The list of causes is long and almost all of it is benign, but two entries on it are not, and both are found by cheap blood tests that nobody runs because the assumption is always that it is the cycle.
What this panel can settle, and by what logic
Eight markers arranged around one clinical guideline's initial workup, because the situation has a defined first set of tests and almost nobody gets them Pozza 2026.
- Estradiol, Sensitive (LC/MS-MS) with Total Testosterone and Free Testosterone is the ratio the tissue responds to, not either number alone. Breast tissue in a man is driven by the balance of estrogen to androgen acting locally, which is why it appears at a normal estradiol when testosterone has fallen and at a normal testosterone when estradiol has risen. The ratio has been reviewed as a measurement in its own right, including how badly it is affected by assay choice Swislocki 2024.
- The estradiol has to be mass spectrometry. Direct immunoassay estradiol is unreliable at male concentrations, and an Endocrine Society position statement was written specifically about the measurement problem Rosner 2013. This panel carries only the LC-MS/MS assay.
- Quantitative beta-hCG is the test that changes the stakes and the one that gets left off. A minority of germ cell tumors secrete hCG, which stimulates testicular aromatase and raises estradiol, and gynecomastia can be the presenting symptom. It sits in the guideline's initial biochemical workup rather than at the end of it Pozza 2026.
- LH & FSH localizes the problem in one pair of numbers. Low testosterone with raised LH and FSH points at the testes; low testosterone with low or normal LH and FSH points above them, and Prolactin is the first thing to read in that pattern Petersenn 2023.
- TSH (Thyroid-Stimulating Hormone) and Comprehensive Metabolic Panel (CMP) cover the two systemic causes that are treatable and cheap to exclude: thyrotoxicosis, which raises SHBG (Sex Hormone-Binding Globulin) and shifts the free hormone balance toward estrogen, and liver disease, which does the same thing by a different route.
What it cannot settle, and what would
It cannot tell you whether what you are feeling is glandular tissue or fat. That is the first question and it is answered by examination, with ultrasound where the examination is unclear Pozza 2026. Fat does not respond to any hormonal treatment, and buying a hormone panel for a chest that is simply fatter is the commonest way to waste this money.
It cannot date the tissue, and the date decides the treatment. Gynecomastia present beyond roughly a year has usually become fibrotic, at which point it stops responding to drugs regardless of what the hormones say Pozza 2026. A perfect panel does not make old tissue reversible.
A raised hCG here is not automatically a tumor, and that matters. Exogenous hCG used in a protocol reads as your own, and false positives from heterophile antibodies are a described and well-characterized problem with a defined resolution pathway Oyatogun 2021. Say what you have taken on the requisition, and ask for a repeat on a different platform before anything drastic happens.
And it cannot image anything. A detectable hCG in a man who has taken none leads to a testicular ultrasound; a markedly raised Prolactin leads to pituitary imaging, after macroprolactin has been excluded on the same sample Smith 2022. Both are the next step, and neither is a blood test.
Draw conditions that decide whether the money is wasted
Four conditions, and the Prolactin is the one that gets ruined most often.
- Morning, ideally 8 to 10am, fasted 9 to 12 hours. Testosterone follows a daily rhythm and an afternoon value is not comparable to the reference intervals it will be judged against.
- Nothing that stimulates prolactin for 24 hours: no nipple or chest stimulation, no heavy pressing, no sexual activity. Then sit quietly for 20 to 30 minutes before the needle, because the stress of the draw itself is a documented cause of a mildly raised result Petersenn 2023.
- If you are on testosterone, draw at trough and write the injection interval on the requisition. The same protocol produces completely different estradiol and testosterone numbers at peak and at trough Swislocki 2024.
- Declare any hCG used in the past three weeks. The assay cannot distinguish your vial from a tumor's output, and an undeclared positive starts an urgent pathway that did not need to start Oyatogun 2021.
How you would know it answered your question, and what each pattern means next
Five patterns, ordered by urgency rather than by likelihood.
- Detectable hCG, Quantitative in a man who has taken none: repeat promptly on a different platform to exclude interference Oyatogun 2021, and see a clinician for a testicular examination and ultrasound without waiting for the rest of the panel to be interpreted.
- Raised Estradiol, Sensitive (LC/MS-MS) with raised Total Testosterone on cycle: aromatization. The conversation is about the protocol, and the marker that should fall if a change works is the estradiol at the same trough timing.
- Low testosterone with raised LH & FSH: a testicular problem. Recheck at 6 to 8 weeks; a persistent pattern is a referral Pozza 2026.
- Low testosterone with low LH & FSH and a raised Prolactin: ask the laboratory to screen the same sample for macroprolactin before anything else Smith 2022, then a clinician.
- Everything normal: common, and informative. It moves the question to the examination and the timeline, which is where gynecomastia is actually settled Pozza 2026.
Sources read for these sections
- Pozza C, et al. Management of gynecomastia in adolescence and adults: the clinical practice guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS). Journal of Endocrinological Investigation 2026 · PMID 42258023
- Oyatogun O, et al. A rational diagnostic approach to the phantom hCG and other clinical scenarios in which a patient is thought to be pregnant but is not. Therapeutic Advances in Reproductive Health 2021 · PMID 34179786
- Rosner W, et al. Challenges to the measurement of estradiol: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2013 · PMID 23463657
- Swislocki ALM, et al. A Review on Testosterone: Estradiol Ratio-Does It Matter, How Do You Measure It, and Can You Optimize It?. World Journal of Men's Health 2024 · PMID 39344113
- Petersenn S, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nature Reviews Endocrinology 2023 · PMID 37670148
- Smith TP, et al. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia. Clinical Chemistry and Laboratory Medicine 2022 · PMID 35708266
The 8 markers — and why each one is here
The mass-spectrometry assay. Standard immunoassay estradiol is not reliable at male levels and this question depends on the number
Total and free by the reference methods — the other half of the ratio that actually drives the tissue
A treatable pituitary cause that suppresses testosterone. Missed constantly because nobody orders it
Determines how much of each hormone is free, and rises in thyrotoxicosis and liver disease
The test that finds the uncommon serious cause. Guideline-recommended in the initial workup, and almost never done
Thyrotoxicosis raises SHBG and shifts the balance toward estrogen. Cheap to exclude
Liver and kidney. Cirrhosis and renal failure both cause gynecomastia and both show here
What this panel is ordered to decide
A panel is a set of numbers until it settles something. These are the decisions this one feeds — each links the pathway it belongs to, what that pathway claims, and what its test list is read for.
Use the sensitive (LC-MS/MS) assay — the standard immunoassay is unreliable at male levels and has driven more unnecessary aromatase-inhibitor use than anything else. More harm is done here by overcorrection than by high estrogen.
Related panels
A panel gives you numbers. Skool is where they get read — 103 marker breakdowns with the optimal range rather than just the lab range, 42 evidence-graded protocols, and me answering questions daily. $10/mo, cancel anytime.
Join Skool — $10/mo →Frequently asked questions
8 markers: Estradiol, Sensitive [LC/MS-MS], Total T [LC/MS] & Free T [Eq. Dialysis], LH & FSH, Prolactin, SHBG (Sex Hormone-Binding Globulin), hCG Beta Subunit, Quantitative, TSH (Thyroid-Stimulating Hormone), Comprehensive Metabolic Panel (CMP).
$232.00 before discount, $208.80 with code CAMERON applied automatically. Individual markers add a one-time $10 draw fee. Ordered through Marek Diagnostics and drawn at any Quest Diagnostics location in the US.
No. These are ordered direct-to-consumer through Marek Diagnostics — you order online, walk into a Quest location, and results are emailed to you in about two weeks. No physician visit or insurance required. Not available in NY, NJ or RI.
Draw in the morning, ideally between 8 and 10am, fasted for the metabolic panel. Prolactin is the one that is easy to ruin: no nipple stimulation, no chest training and no sexual activity for 24 hours, and sit quietly for 20-30 minutes before the draw, because venepuncture stress alone raises it. If you are on TRT, draw at trough and record where you are in the injection cycle. If you have used hCG in the past three weeks, note it — the test cannot tell your dose from a tumor's output.
Raised estradiol with a raised or high-normal testosterone in someone on cycle is aromatization and the conversation is about the protocol. Low testosterone with high LH and FSH points at the testes; low testosterone with low LH and FSH points above them, and prolactin is the first thing to read in that pattern. A detectable hCG in a man who has not taken any is a finding that needs a clinician and a testicular ultrasound, promptly, whatever the rest of the panel says. A completely normal panel is common and is itself informative: it moves the question to the examination and the timeline.
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.